Literature DB >> 19596463

Rectal cancer multidisciplinary management: evidences and future landscape.

David Sebag-Montefiore, Krzysztof Bujko, Vincenzo Valentini.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19596463     DOI: 10.1016/j.radonc.2009.06.026

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  6 in total

1.  Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy.

Authors:  Yifan Peng; Lin Wang; Changzheng Du; Jin Gu
Journal:  Int J Colorectal Dis       Date:  2012-05-30       Impact factor: 2.571

2.  Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study.

Authors:  Chang-Zheng Du; Yong-Chun Chen; Yong Cai; Wei-Cheng Xue; Jin Gu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

3.  Role of radiation therapy in neoadjuvant era in patients with locally advanced rectal cancer.

Authors:  Georgios V Koukourakis
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

4.  Circumferential resection margins of rectal tumours post-radiotherapy: how can MRI aid surgical planning?

Authors:  E R McGlone; V Shah; C Lowdell; D Blunt; P Cohen; P M Dawson
Journal:  Tech Coloproctol       Date:  2014-07-19       Impact factor: 3.781

5.  Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.

Authors:  Florian Sterzing; Frieder Hoehle; Alexis Ulrich; Alexandra Jensen; Jürgen Debus; Marc Muenter
Journal:  J Radiat Res       Date:  2014-10-23       Impact factor: 2.724

6.  A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients.

Authors:  Trude C Frøseth; Trond Strickert; Kjersti S Solli; Øyvind Salvesen; Gunilla Frykholm; Randi J Reidunsdatter
Journal:  Radiat Oncol       Date:  2015-10-27       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.